CUSIP 687604108 · who reports it, how much, and how much it matters to them
33 of the 720 hedge fund managers we track reported shares of Oruka Therapeutics, Inc. (Nasdaq: ORKA) on Form 13F for 30 June 2026. Between them they reported USD 1.8bn. The largest position belongs to Fairmount Funds Management, at USD 353m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Fairmount Funds Management2 funds on PPLI.com | USD 353m | 23.3% |
| 2 | RTW Investments2 funds on PPLI.com | USD 299m | 2.6% |
| 3 | Deep Track Capital1 fund on PPLI.com | USD 183m | 2.7% |
| 4 | Ra Capital Management1 fund on PPLI.com | USD 148m | 1.3% |
| 5 | Viking Global Investors4 funds on PPLI.com | USD 143m | 0.4% |
| 6 | Perceptive Advisors6 funds on PPLI.com | USD 128m | 1.9% |
| 7 | Polar Capital LLP26 funds on PPLI.com | USD 117m | 0.3% |
| 8 | Citadel Advisors32 funds on PPLI.com | USD 106m | 0.0% |
| 9 | Summit Partners Public Asset Management14 funds on PPLI.com | USD 63m | 1.1% |
| 10 | Cormorant Asset Management1 fund on PPLI.com | USD 51m | 2.6% |
| 11 | Adage Capital Management1 fund on PPLI.com | USD 34m | 0.0% |
| 12 | Holocene Advisors2 funds on PPLI.com | USD 29m | 0.1% |
| 13 | Braidwell12 funds on PPLI.com | USD 26m | 1.0% |
| 14 | Great Point Partners2 funds on PPLI.com | USD 17m | 3.3% |
| 15 | Sio Capital Management4 funds on PPLI.com | USD 17m | 2.8% |
| 16 | PFM Health Sciences3 funds on PPLI.com | USD 15m | 1.3% |
| 17 | Exoduspoint Capital Management7 funds on PPLI.com | USD 14m | 0.1% |
| 18 | Apis Capital Advisors4 funds on PPLI.com | USD 11m | 1.0% |
| 19 | Atika Capital Management3 funds on PPLI.com | USD 9.5m | 0.6% |
| 20 | Burkehill Global Management5 funds on PPLI.com | USD 4.8m | 0.2% |
| 21 | HighVista Strategies27 funds on PPLI.com | USD 4m | 0.9% |
| 22 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 3.3m | 0.0% |
| 23 | Palo Alto Investors6 funds on PPLI.com | USD 3.2m | 0.4% |
| 24 | Artia Global Partners1 fund on PPLI.com | USD 3.2m | 0.6% |
| 25 | Millennium Management6 funds on PPLI.com | USD 3.1m | 0.0% |
| 26 | Freestone Grove Partners1 fund on PPLI.com | USD 2.1m | 0.0% |
| 27 | Atom Investors1 fund on PPLI.com | USD 1.5m | 0.1% |
| 28 | J. Goldman & Co.1 fund on PPLI.com | USD 1.2m | 0.0% |
| 29 | Rock Springs Capital Management2 funds on PPLI.com | USD 1.1m | 0.1% |
| 30 | Balyasny Asset Management25 funds on PPLI.com | USD 1.1m | 0.0% |
| 31 | Persistent Asset Partners10 funds on PPLI.com | USD 674,000 | 0.2% |
| 32 | Engineers Gate Manager1 fund on PPLI.com | USD 350,000 | 0.0% |
| 33 | Voleon Capital Management13 funds on PPLI.com | USD 339,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Fairmount Funds Management | USD 353m | 23.3% |
| 2 | Great Point Partners | USD 17m | 3.3% |
| 3 | Sio Capital Management | USD 17m | 2.8% |
| 4 | Deep Track Capital | USD 183m | 2.7% |
| 5 | Cormorant Asset Management | USD 51m | 2.6% |
| 6 | RTW Investments | USD 299m | 2.6% |
| 7 | Perceptive Advisors | USD 128m | 1.9% |
| 8 | PFM Health Sciences | USD 15m | 1.3% |
| 9 | Ra Capital Management | USD 148m | 1.3% |
| 10 | Summit Partners Public Asset Management | USD 63m | 1.1% |
Oruka Therapeutics, Inc. trades under the symbol ORKA on the Nasdaq. Its CUSIP, the code used on Form 13F, is 687604108.
33 of the 720 hedge fund managers PPLI.com tracks reported Oruka Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Fairmount Funds Management (USD 353m), RTW Investments (USD 299m), Deep Track Capital (USD 183m), Ra Capital Management (USD 148m) and Viking Global Investors (USD 143m).
33 managers in our coverage reported it, and between them they run 256 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Fairmount Funds Management, where the position was 23.3% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Oruka Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.